Epithelial Membrane Protein-2 (EMP2) and Experimental Proliferative Vitreoretinopathy (PVR)

Author： Telander David G.   Morales Shawn A.   Mareninov Sergey   Forward Krisztina   Gordon Lynn K.  

Publisher： Informa Healthcare

ISSN： 0271-3683

Source： Current Eye Research, Vol.36, Iss.6, 2011-06, pp. : 546-552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Pharmacologic Therapy in a Rabbit Model of Proliferative Vitreoretinopathy (PVR)

By  

Ophthalmic Research, Vol. 32, Iss. 1, 2000-02 ,pp. : 25-29

Karger

Access to resources Recommend Favorite

Inhibition of Experimental Proliferative Vitreoretinopathy with Protein Kinase C Inhibitor (Chelerythrine Chloride) and Melatonin

By  

Ophthalmologica, Vol. 220, Iss. 1, 2005-12 ,pp. : 17-22

Karger

Access to resources Recommend Favorite

The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy

By Tahara Yoshihisa   Sakamoto Taiji   Oshima Yuji   Ishibashi Tatsuro   Inomata Hajime   Murata Toshinori   Hinton David R.   Ryan Stephen J.  

Current Eye Research, Vol. 19, Iss. 4, 1999-10 ,pp. : 323-329

Informa Healthcare

Access to resources Recommend Favorite

The role of retinotomy in an experimental rabbit model of proliferative vitreoretinopathy

By Goldaracena M. Begoña   Garcia-Layana Alfredo   Pastor J. Carlos   Saornil María A.   de la Fuente Francisco   Gayoso Manuel J.  

Current Eye Research, Vol. 16, Iss. 5, 1997-05 ,pp. : 422-427

Informa Healthcare

Access to resources Recommend Favorite

Experimental Model for Proliferative Vitreoretinopathy by Intravitreal Dispase: Limited by Zonulolysis and Cataract

By  

Ophthalmologica, Vol. 220, Iss. 4, 2006-06 ,pp. : 211-216

Karger

Access to resources Recommend Favorite